Efficacy of anti-epileptic drugs in patients with gliomas and seizures

Journal of Neurology

Volumn 256, Issue 9, 2009, Pages 1519-1526

  Van Breemen, Mèlanie S M ^a   Rijsman, R M ^a   Taphoorn, M J B ^a   Walchenbach, R ^a   Zwinkels, H ^a   Vecht, Charles J ^a  

^a Medical Center the Hague   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; TEMOZOLOMIDE; TOPIRAMATE; VALPROIC ACID; VINCRISTINE;

ADULT; ARTICLE; BRAIN METASTASIS; BRAIN TUMOR; CANCER SURVIVAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG WITHDRAWAL; EPENDYMOMA; EPILEPSY; FEMALE; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; MULTIPLE CYCLE TREATMENT; NAUSEA; PRIORITY JOURNAL; SEIZURE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTICONVULSANTS; BRAIN NEOPLASMS; CARBAMAZEPINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PIRACETAM; SEIZURES; TIME FACTORS; TREATMENT OUTCOME; TRIAZINES; VALPROIC ACID;

EID: 69549127978     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-009-5156-9     Document Type: Article

References (29)

1. PL Moots RJ Maciunas DR Eisert RA Parker K Laporte B Abou-Khalil 1995 The course of seizure disorders in patients with malignant gliomas Arch Neurol 52 717 724
2. MS van Breemen EB Wilms CJ Vecht 2007 Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management Lancet Neurol 6 421 430 10.1016/S1474-4422(07)70103-5 (Pubitemid 46551867)
3. JF Hildebrand CF Lecaille JF Perennes JY Delattre 2005 Epileptic seizures during follow-up of patients treated for primary brain tumors Neurology 65 212 215 10.1212/01.wnl.0000168903.09277.8f (Pubitemid 41022363)
4. W Wick O Menn C Meisner J Steinbach M Hermisson M Tatagiba M Weller 2005 Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long? Onkologie 28 391 396 10.1159/000086375 (Pubitemid 41558255)
5. GL Wagner EB Wilms CA Van Donselaar C Vecht 2003 Levetiracetam: preliminary experience in patients with primary brain tumours Seizure 12 585 586 10.1016/S1059-1311(03)00096-7 (Pubitemid 37509054)
6. S Eyal B Yagen E Sobol Y Altschuler M Shmuel M Bialer 2004 The activity of antiepileptic drugs as histone deacetylase inhibitors Epilepsia 45 737 744 10.1111/j.0013-9580.2004.00104.x (Pubitemid 38890970)
7. XN Li Q Shu JM Su L Perlaky SM Blaney CC Lau 2005 Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC Mol Cancer Ther 4 1912 1922 10.1158/1535-7163.MCT-05-0184 (Pubitemid 43056974)
8. DN Louis H Ohgaki OD Wiestler WK Cavenee PC Burger A Jouvet BW Scheithauer P Kleihues 2007 The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 97 109 10.1007/s00401-007-0243-4
9. A Chavez-Blanco C Perez-Plasencia E Perez-Cardenas C Carrasco-Legleu E Rangel-Lopez B Segura-Pacheco L Taja-Chayeb C Trejo-Becerril A Gonzalez-Fierro M Candelaria G Cabrera A Duenas-Gonzalez 2006 Antineoplastic effects of the DNA methylation inhibitor hydralazine and the histone deacetylase inhibitor valproic acid in cancer cell lines Cancer Cell Int 6 2 22 33 10.1186/1475-2867-6-2
10. AD Norden PY Wen 2006 Glioma therapy in adults Neurologist 12 279 292 10.1097/01.nrl.0000250928.26044.47 (Pubitemid 44813664)
11. Stupp RF, Mason WPFAU, van den Bent M, van den Bent MJFAU, Weller M, Weller MF, Fisher BF, Taphoorn MJFAU, Belanger K, Belanger KF, Brandes AAFAU, Marosi C, Marosi CF, Bogdahn UF, Curschmann JF, Janzer RCFAU, Ludwin S, Ludwin SKFAU, Gorlia T, Gorlia TF, Allgeier AF, Lacombe DF, Cairncross JGFAU, Eisenhauer E, Eisenhauer EFAU, Mirimanoff R, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 10:987-996. doi: 10.1056/NEJMoa043330 (Pubitemid 40349501)
12. GA Van der Sanden LJ Schouten JA van Dijck JP van Andel RW van der Maazen JW Coebergh 2002 Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands Cancer 94 1548 1556 10.1002/cncr.10357 (Pubitemid 34212650)
13. ST Herman 2002 Epilepsy after brain insult: targeting epileptogenesis Neurology 59 S21 S26
14. GD Cascino 1990 Epilepsy and brain tumors: implications for treatment Epilepsia 31 Suppl 3 S37 S44 10.1111/j.1528-1157.1990.tb05858.x
15. HP Bootsma L Ricker L Diepman J Gehring J Hulsman D Lambrechts L Leenen M Majoie A Schellekens M de Krom AP Aldenkamp 2007 Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center Epilepsy Behav 10 296 303 10.1016/j.yebeh.2006.11.016 (Pubitemid 46432220)
16. P Genton B Sadzot N Fejerman J Peltola PA Despland B Steinhoff I Rektor S Wroe MC Maubrey C Vandervelden G van Hammee AF Schlit W van Paesschen 2006 Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial Acta Neurol Scand 113 387 394 10.1111/j.1600-0404.2006.00647.x (Pubitemid 44046324)
17. P Kinirons M McCarthy CP Doherty N Delanty 2006 Predicting drug-resistant patients who respond to add-on therapy with levetiracetam Seizure 15 387 392 10.1016/j.seizure.2006.05.001 (Pubitemid 44184811)
18. MJ Brodie LJ Stephen 2007 Outcomes in elderly patients with newly diagnosed and treated epilepsy Int Rev Neurobiol 81 253 263 10.1016/S0074- 7742(06)81016-0
19. DM Hermann E Kilic A Spudich SD Kramer H Wunderli-Allenspach CL Bassetti 2006 Role of drug efflux carriers in the healthy and diseased brain Ann Neurol 60 489 498 10.1002/ana.21012 (Pubitemid 44871789)
20. C Calatozzolo M Gelati E Ciusani FL Sciacca B Pollo L Cajola C Marras A Silvani L Vitellaro-Zuccarello D Croci A Boiardi A Salmaggi 2005 Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma J Neurooncol 74 113 121 10.1007/s11060-004-6152-7 (Pubitemid 41478906)
21. R Coupez JM Nicolas TR Browne 2003 Levetiracetam, a new antiepileptic agent: lack of in vitro and in vivo pharmacokinetic interaction with valproic acid Epilepsia 44 171 178 10.1046/j.1528-1157.2003.25302.x (Pubitemid 36206018)
22. CJ Vecht GL Wagner EB Wilms 2003 Interactions between antiepileptic and chemotherapeutic drugs Lancet Neurol 2 404 409 10.1016/S1474-4422(03)00435-6 (Pubitemid 36793932)
23. M Maschio F Albani A Baruzzi A Zarabla L Dinapoli A Pace A Pompili CM Carapella E Occhipinti B Jandolo 2006 Levetiracetam therapy in patients with brain tumour and epilepsy J Neurooncol 80 97 100 10.1007/s11060-006-9162-9 (Pubitemid 44473268)
24. HB Newton SA Goldlust D Pearl 2006 Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients J Neurooncol 78 99 102 10.1007/s11060-005-9070-4 (Pubitemid 43786667)
25. LM Lynam MK Lyons JF Drazkowski JI Sirven KH Noe RS Zimmerman JA Wilkens 2007 Frequency of seizures in patients with newly diagnosed brain tumors: a retrospective review Clin Neurol Neurosurg 109 634 638 10.1016/j.clineuro.2007. 05.017 (Pubitemid 47016762)
26. C Otoul C Arrigo K Van Rijckevorsel JA French 2005 Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy Clin Neuropharmacol 28 72 78 10.1097/01.wnf. 0000159956.87511.67 (Pubitemid 40471880)
27. K Van Rijckevorsel PA Boon 2001 The 'number needed to treat' with Levetiracetam (LEV): comparison with the other new antiepileptic drugs (AEDs) Seizure 10 235 236 10.1053/seiz.2001.0497 (Pubitemid 32624516)
28. MJ Van den Bent M Reni G Gatta C Vecht 2008 Oligodendroglioma Crit Rev Oncol Hematol 66 262 272 10.1016/j.critrevonc.2007.11.007
29. ML Van Veelen CJ Avezaat JM Kros W van Putten C Vecht 1998 Supratentorial low grade astrocytoma: prognostic factors, dedifferentiation, and the issue of early versus late surgery J Neurol Neurosurg Psychiatry 64 581 587 10.1136/jnnp.64.5.581